If you work in generic pharma portfolio management, chances are you spend epic amounts of time locked up with a spreadsheet the size of a small continent. Molecules and dosage forms, therapeutic areas, sales channels, market shares, LoE dates, patent minefields to traverse, bioequivalence complexities, API costs and dossier suppliers, capacity constraints and on, and…